JPMorgan Cuts Ties with Polymarket Amid Regulatory Crackdown, Eyes Future IPO Role

JPMorgan Chase, the largest bank in the United States, has severed its banking relationship with decentralized prediction market Polymarket amid escalating regulatory pressures, yet remains open to playing an underwriting role should the platform decide to go public.

Regulatory Pressure Severs Banking Lifelines

According to a report by the Financial Times, JPMorgan notified Polymarket in early October 2025 that it needed to find a new banking partner, citing regulatory concerns. This move underscores the intensifying scrutiny facing prediction markets globally.

■The bank officially terminated its commercial banking ties with Polymarket.

■The platform has transitioned to operations with an unidentified lending institution.

■More than a dozen U.S. states have initiated legal actions against Polymarket and its competitor Kalshi regarding sports event contracts.

The IPO Paradox: Cutting Ties but Keeping the Door Open

Despite the termination of banking services, JPMorgan’s interest in the platform has not entirely waned. The bank is allegedly keen on securing a potential underwriting role if Polymarket attempts an Initial Public Offering (IPO).

■JPMorgan is targeting a lead role in a potential Polymarket IPO.

■Polymarket representatives confirmed they continue to maintain a "close, active relationship" with the banking giant.

■Authorities in several countries, including Argentina, have recently blocked or restricted access to the platform.

In the DeFi ecosystem, such fractures are becoming the norm rather than the exception. Traditional Finance (TradFi) institutions are distancing themselves operationally to mitigate regulatory risk, yet they remain eager to chase fees as investment banks. This situation reinforces the imperative for crypto-native companies to build their own infrastructure. While short-term volatility in Polymarket's TVL and liquidity pools is inevitable, the prospect of an IPO signals a potential "exit strategy" for institutional investors navigating the regulatory minefield.